CCTA is safe and effective, and saves time when assessing patients at low- to intermediate-risk of a heart attack.
Coronary CT angiography (CCTA) in the emergency department is safe and effective, and saves time when assessing patients at low- to intermediate-risk of a heart attack, according to a study published online in the New England Journal of Medicine and presented at the American College of Cardiology 61st Annual Scientific Session.
Researchers from the Perelman School of Medicine at the University of Pennsylvania undertook the large, multicenter American College of Radiology Imaging Network (ACRIN) trial to confirm that CCTA was safe to use in patients with suspected heart attacks, allowing ED physicians the confidence to triage low- to intermediate-risk patients according to the scan’s results.
“Prior research, including work by our research team at Penn, established that CCTA can rapidly identify the extent of coronary artery disease, if present, and suggested the safety of CCTA for clinical decision making,” said Harold I. Litt, MD, PhD, chief of cardiovascular imaging in the Department of Radiology at the university.
RELATED: Early CT Angiography Identifies Recurrent Stroke Risk
The study included 908 low- to intermediate-risk patients with chest pain, who were assigned to the CCTA rapid rule-out strategy group, and 462 who were treated traditionally. Patients from both groups whose testing showed heart muscle injury were admitted to the hospital and those with negative tests were discharged. Patients who had negative tests were called 30 days after enrollment for follow up. No deaths within 30 days of discharge were reported among the 640 patients who had negative CCTA results.
“The trial results have significant potential to establish a new standard of care for low- to intermediate-risk patients, dramatically reduce health care utilization and lower medical costs,” said Judd Hollander, MD, co-principal investigator and clinical research director in the Department of Emergency Medicine at the University of Pennsylvania. “In addition to identifying the patients who could safely be discharged, the trial results showed evaluation with CCTA compared with current practice led to fewer patients having cardiac catheterizations that were found to be unnecessary and identified more patients that truly required hospital care.”
There will be more information available from this trial. “The trial’s secondary aims of comparing health care utilization of the two arms and their respective patient outcomes at one-year follow-up will also be important data to report, given the increasing scrutiny of health-care delivery costs,” said Pamela K. Woodard, MD, head of advanced imaging at Washington University School of Medicine and chair of ACRIN’s Cardiovascular Committee.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.